miR‐200b‐3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.

MLA

Wu, Yu‐Zhu, et al. “MiR‐200b‐3p Mitigates Oxaliplatin Resistance via Targeting TUBB3 in Colorectal Cancer.” Journal of Gene Medicine, vol. 22, no. 7, July 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1002/jgm.3178.

APA

Wu, Y., Lin, H., Zhang, Y., & Chen, W. (2020). miR‐200b‐3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer. Journal of Gene Medicine, 22(7), 1–10. https://doi.org/10.1002/jgm.3178

Chicago

Wu, Yu‐Zhu, Hong‐Yue Lin, Yin Zhang, and Wen‐Fa Chen. 2020. “MiR‐200b‐3p Mitigates Oxaliplatin Resistance via Targeting TUBB3 in Colorectal Cancer.” Journal of Gene Medicine 22 (7): 1–10. doi:10.1002/jgm.3178.